Sonja C S Simon
Overview
Explore the profile of Sonja C S Simon including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
130
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Simon S, Bibi I, Schaffert D, Benecke J, Martin N, Leipe J, et al.
Bioengineering (Basel)
. 2025 Jan;
11(12.
PMID: 39768090
Background: The COVID-19 pandemic severely impacted healthcare systems, affecting patient outcomes and resource allocation. This study applied automated machine learning (AutoML) to analyze key health outputs, such as discharge conditions,...
2.
Simon S, Muller V, Utikal J
Front Oncol
. 2023 Mar;
13:1111119.
PMID: 36959781
Mutations in the gene are common alterations in malignant melanoma. However, there are no specific treatment options approved for -mutated melanoma patients besides immune checkpoint inhibition. Since preclinical data suggests...
3.
Petrova V, Groth C, Bitsch R, Arkhypov I, Simon S, Hetjens S, et al.
Front Immunol
. 2023 Mar;
14:1065767.
PMID: 36860876
Purpose: Although the treatment of advanced melanoma patients with immune checkpoint inhibitors (ICI) significantly increased the therapeutic efficiency, many patients remain resistant to ICI that could be due to immunosuppression...
4.
Gebhardt C, Simon S, Weber R, Gries M, Mun D, Reinhard R, et al.
Cell Immunol
. 2020 Dec;
360:104274.
PMID: 33383383
The low dose application of chemotherapeutic agents such as paclitaxel was previously shown to initiate anti-tumor activity by neutralizing myeloid-derived suppressor cells (MDSCs) in melanoma mouse models. Here, we investigated...
5.
Simon S, Hu X, Panten J, Grees M, Renders S, Thomas D, et al.
Oncoimmunology
. 2020 Mar;
9(1):1727116.
PMID: 32117594
Eosinophils have been identified as a prognostic marker in immunotherapy of melanoma and suggested to contribute to anti-tumor host defense. However, the influence of immune checkpoint inhibitors (ICI) on the...
6.
Simon S, Utikal J, Umansky V
Cancer Immunol Immunother
. 2018 Oct;
68(5):823-833.
PMID: 30302498
Eosinophils are a subset of granulocytes mostly known for their ability to combat parasites and induce allergy. Although they were described to be related to cancer more than 100 years...